In this case study analysis, Njogu and colleagues examine how health care workers in Kenya, India, and Nigeria have communicated to promote HPV vaccine uptake at different stages of national rollout. In Kenya, a multisectoral approach and myth-busting training proved critical; in Sikkim (India), intensive social mobilization and cascade training underpinned a successful subnational introduction; […]
Country: Nigeria
Défis et bonnes pratiques pour maintenir la prestation après l’introduction du MAC: l’expérience du Nigéria dans l’élimination du cancer du col de l’utérus
Au Nigéria, la vaccination contre le HPV a été introduite en deux phases — Phase 1 ciblant 16 États (2023) et Phase 2 couvrant 21 États supplémentaires (octobre 2024) — avec une routinisation immédiate après chaque campagne de cohortes multi-âges (MAC). La combinaison des campagnes et de la vaccination de routine a permis d’atteindre environ […]
Panorama situationnel du HPV – Nigeria
Au Nigéria, le vaccin HPV a été introduit à l’échelle nationale en octobre 2023 via une approche progressive par cohortes multi-âges (MAC) avec une dose unique du vaccin recombinant quadrivalent, couvrant 16 États et le FCT en phase 1, puis les 21 États restants en mai 2024. La cible initiale (9–14 ans) a été restreinte […]
Communication And Dialogue With Islamic Religious Scholars: A Focus Group Discussion To Enhance Human Papillomavirus Vaccine Awareness And Uptake In Northern Nigeria
In northern Nigeria, a focus group discussion with 13 senior Islamic scholars (Imams) from diverse ideological backgrounds was conducted in Gombe one week before the state’s HPV vaccine launch in May 2024, with the aim of surfacing barriers to vaccine acceptance and building religious endorsement ahead of rollout. Scholars reached consensus that Islam permits — […]
Using Routine Human Papillomavirus Vaccination Data to Guide High-Impact Community Outreach in Nigeria
In Nigeria, routine HPV vaccination coverage among nine-year-old girls remains low in Kano State, constrained by limited awareness, persistent myths, and geographic and economic barriers. Pathfinder International used DHIS2 data to identify low-coverage local government areas and implemented targeted community outreach in collaboration with State Primary Health Care Development Boards, deploying trained vaccination teams alongside […]
Improved HPV Vaccination by co-designing a context-specific Integrated Health Service Delivery Package in Kebbi and Lagos State, Nigeria: Human-Centered Design Approach.
In Nigeria, sustaining HPV vaccination and transitioning to routine delivery following the 2023 multi-age cohort campaign remain significant challenges. As part of the SHARP multi-country study, human-centered design (HCD) workshops in Agege LGA (Lagos) and Gwandu LGA (Kebbi) engaged 55 stakeholders across community, facility, LGA, state, and national levels to co-design locally tailored integrated service […]
Laying the groundwork for adolescent-centred HPV services: Formative Insights from Stakeholder Consultations in Lagos and Kebbi States, Nigeria
In Nigeria, formative stakeholder consultations conducted across Lagos and Kebbi states engaged 88 key informants — including national programme managers, adolescent girls, caregivers, community leaders, health workers, teachers, and LGA managers — to identify barriers and facilitators for integrating HPV vaccination with adolescent primary health care services as part of the SHARP implementation research programme. […]
Challenges and good practices for sustaining delivery after a MAC introduction: Nigeria’s experience towards cervical cancer elimination
In Nigeria, HPV vaccination was introduced in two phases — Phase 1 targeting 16 states (2023) and Phase 2 covering 21 additional states (October 2024) — with immediate routinization following each mass multi-age cohort (MAC) campaign. Combined MAC and routine delivery reached approximately 15.3 million girls aged 9–14 since introduction, with over 12.3 million vaccinated […]
Country Snapshot – Nigeria
In Nigeria, the HPV vaccine was introduced nationwide in October 2023 using a phased multi-age cohort (MAC) approach with a single-dose quadrivalent recombinant vaccine, covering 16 states and the FCT in Phase 1 and the remaining 21 states in May 2024. The initial target was girls aged 9–14, narrowed to 9-year-olds only from January 2025. […]
Mobilisation sociale (y compris les chefs religieux), communication et formation des professionnels de la santé : l’expérience d’introduction du Nigéria
La présentation retrace l’introduction progressive du vaccin HPV au Nigéria, en mettant l’accent sur la mobilisation sociale, la communication et la formation lors de la première campagne multi-tranches d’âge. Elle souligne le rôle déterminant de l’engagement politique, de l’implication des parties prenantes et des actions médiatiques pour atteindre une couverture élevée. Les défis rencontrés incluent […]